The Psychedelics and Psychoplastogens Summit
From altered states to lasting change.
Psychedelics and psychoplastogens are opening new questions about how the brain changes, heals, and sustains recovery. This summit brings together neuroscientists, clinicians, drug developers, care-delivery leaders, regulators, and investors to examine the science, translation, and responsible deployment of compounds designed to promote durable neural and behavioral change.
In the room
Neuroscientists, psychiatrists and psychologists, translational researchers, drug developers, care-delivery leaders, regulators, and investors.
On the table
- Mechanisms of neuroplasticity and durable therapeutic change
- Psychedelic-assisted care: evidence, safety, and clinical models
- Next-generation psychoplastogens and non-hallucinogenic compounds
- Trial design, biomarkers, and patient selection
- Regulation, reimbursement, access, and responsible commercialization
Status
February 18–21, 2027 · The Thyme · Forty seats
Invited guests
Already hold an invitation to Psychedelics and Psychoplastogens Summit?
Confirm your registrationPlasticity opens the window. Science and care shape what follows.
Join the room